{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:16:05Z","timestamp":1791821765768,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.modpat.2023.100104","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T11:37:26Z","timestamp":1674473846000},"page":"100104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["High-Grade Sarcomas with Myogenic Differentiation Harboring Hotspot PDGFRB Mutations"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1139-2914","authenticated-orcid":false,"given":"Josephine K.","family":"Dermawan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martee L.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Tap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina R.","family":"Antonescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.modpat.2023.100104_bib1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ijc.2910530405","article-title":"Expression of functional PDGF beta receptors in a human large-cell lung-carcinoma cell line","volume":"53","author":"Forsberg","year":"1993","journal-title":"Int J Cancer"},{"issue":"16","key":"10.1016\/j.modpat.2023.100104_bib2","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1101\/gad.8.16.1888","article-title":"Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice","volume":"8","author":"Soriano","year":"1994","journal-title":"Genes Dev"},{"issue":"20","key":"10.1016\/j.modpat.2023.100104_bib3","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1242\/dev.00721","article-title":"Roles of PDGF in animal development","volume":"130","author":"Hoch","year":"2003","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.modpat.2023.100104_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/PAS.0000000000000752","article-title":"Recurrent somatic PDGFRB mutations in sporadic infantile\/solitary adult myofibromas but not in angioleiomyomas and myopericytomas","volume":"41","author":"Agaimy","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2023.100104_bib5","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/PAS.0000000000000862","article-title":"Myopericytomatosis: clinicopathologic analysis of 11 cases with molecular identification of recurrent PDGFRB alterations in myopericytomatosis and myopericytoma","volume":"41","author":"Hung","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2023.100104_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/1066896919876703","article-title":"A\u00a0distinctive genomic and immunohistochemical profile for notch3 and PDGFRB in myofibroma with diagnostic and therapeutic implications","volume":"28","author":"Koo","year":"2020","journal-title":"Int J Surg Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2023.100104_bib7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ajhg.2013.04.026","article-title":"A\u00a0recurrent PDGFRB mutation causes familial infantile myofibromatosis","volume":"92","author":"Cheung","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.modpat.2023.100104_bib8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.ajhg.2013.04.024","article-title":"Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis","volume":"92","author":"Martignetti","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.modpat.2023.100104_bib9","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/hmg\/ddx081","article-title":"PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis","volume":"26","author":"Arts","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"25","key":"10.1016\/j.modpat.2023.100104_bib10","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1038\/onc.2015.383","article-title":"PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib","volume":"35","author":"Arts","year":"2016","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.modpat.2023.100104_bib11","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a004440","article-title":"Novel PDGFRB rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinib","volume":"5","author":"Hassan","year":"2019","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"2","key":"10.1016\/j.modpat.2023.100104_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5382","article-title":"Avoidance of surgery for head and neck infantile myofibromatosis using imatinib monotherapy","volume":"10","author":"Pattisapu","year":"2022","journal-title":"Clin Case Rep"},{"issue":"3","key":"10.1016\/j.modpat.2023.100104_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): A hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J\u00a0Mol Diagn"},{"issue":"18","key":"10.1016\/j.modpat.2023.100104_bib14","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.modpat.2023.100104_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","article-title":"Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation","volume":"77","author":"Golub","year":"1994","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.modpat.2023.100104_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cancergencyto.2007.03.004","article-title":"Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia","volume":"176","author":"Crescenzi","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"issue":"9","key":"10.1016\/j.modpat.2023.100104_bib17","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2014.105452","article-title":"PDGFRB-rearranged T-lymphoblastic leukemia\/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin","volume":"99","author":"Ondrejka","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.modpat.2023.100104_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00019606-199909000-00002","article-title":"Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues","volume":"8","author":"Wang","year":"1999","journal-title":"Diagn Mol Pathol"},{"issue":"14","key":"10.1016\/j.modpat.2023.100104_bib19","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1242\/dev.126.14.3047","article-title":"Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse","volume":"126","author":"Hellstr\u00f6m","year":"1999","journal-title":"Development"},{"issue":"3","key":"10.1016\/j.modpat.2023.100104_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s13277-010-0138-1","article-title":"Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers","volume":"32","author":"Koivisto-Korander","year":"2011","journal-title":"Tumour Biol"},{"issue":"18","key":"10.1016\/j.modpat.2023.100104_bib21","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1002\/cncr.24486","article-title":"Cluster analysis of immunohistochemical markers in leiomyosarcoma delineates specific anatomic and gender subgroups","volume":"115","author":"Carvalho","year":"2009","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.modpat.2023.100104_bib22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00000478-200204000-00001","article-title":"An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies","volume":"26","author":"Oliva","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2023.100104_bib23","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cell.2017.10.014","article-title":"Comprehensive and integrated genomic characterization of adult soft tissue sarcomas","volume":"171","year":"2017","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.modpat.2023.100104_bib24","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1158\/1078-0432.CCR-19-3959","article-title":"Genomic landscape of uterine sarcomas defined through prospective clinical sequencing","volume":"26","author":"Hensley","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.modpat.2023.100104_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3802\/jgo.2014.25.4.306","article-title":"Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients","volume":"25","author":"Tirumani","year":"2014","journal-title":"J\u00a0Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.modpat.2023.100104_bib26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/CCO.0000000000000094","article-title":"Management of advanced uterine leiomyosarcoma","volume":"26","author":"Hyman","year":"2014","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"10.1016\/j.modpat.2023.100104_bib27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JCO.2017.75.9845","article-title":"Soft tissue and uterine leiomyosarcoma","volume":"36","author":"George","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2023.100104_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2008.03.010","article-title":"Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial","volume":"109","author":"Hensley","year":"2008","journal-title":"Gynecol Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522300008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522300008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:23:10Z","timestamp":1760232190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522300008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S089339522300008X"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100104","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Grade Sarcomas with Myogenic Differentiation Harboring Hotspot PDGFRB Mutations","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100104"}}